Platelet rich fibrin as a bioactive matrix with proosteogenic and proangiogenic properties on human healthy primary cells in vitro

Eva Dohle,Lena Schmeinck,Kamelia Parkhoo,Robert Sader,Shahram Ghanaati
DOI: https://doi.org/10.1080/09537104.2024.2316744
2024-02-24
Platelets
Abstract:Blood concentrates like platelet rich fibrin (PRF) have been established as a potential autologous source of cells and growth factors with regenerative properties in the field of dentistry and regenerative medicine. To further analyze the effect of PRF on bone tissue regeneration, this study investigated the influence of liquid PRF matrices on human healthy primary osteoblasts (pOB) and co-cultures composed of pOB and human dermal vascular endothelial cells (HDMEC) as in vitro model for bone tissue regeneration. Special attention was paid to the PRF mediated influence on osteoblastic differentiation and angiogenesis. Based on the low-speed centrifugation concept, cells were treated indirectly with PRF prepared with a low (44 g) and high relative centrifugal force (710 g) before the PRF mediated effect on osteoblast proliferation and differentiation was assessed via gene and protein expression analyses and immunofluorescence. The results revealed a PRF-mediated positive effect on osteogenic proliferation and differentiation accompanied by increased concentration of osteogenic growth factors and upregulated expression of osteogenic differentiation factors. Furthermore, it could be shown that PRF treatment resulted in an increased formation of angiogenic structures in a bone tissue mimic co-culture of endothelial cells and osteoblasts induced by the PRF mediated increased release of proangiogenic growth factors. The effects on osteogenic proliferation, differentiation and vascularization were more evident when low RCF PRF was applied to the cells. In conclusion, PRF possess proosteogenic, potentially osteoconductive as well as proangiogenic properties, making it a beneficial tool for bone tissue regeneration. What is the context? The treatment of bone defects is still a challenge in the field of regenerative medicine. In this context, researchers and clinicians are continuously focusing on developing new therapeutic strategies like the use of autologous blood concentrates like Platelet rich fibrin (PRF) to improve regeneration by directly delivering wound healing promoting cells and growth factors to the defect side in order to restore the structure and functional integrity of damaged hard tissue in combination with adequate tissue regeneration. What is new? Focus of the present in vitro study was to further evaluate the potential of PRF paying particular attention to the PRF-mediated effect on osteogenic differentiation and angiogenesis of human primary osteoblasts as well as on a more complex tissue like co-culture consisting of osteoblasts and microvascular endothelial cells. We could demonstrate that PRF is able to support and affect a variety of processes involved in bone tissue regeneration including osteogenic proliferation, osteogenic differentiation as well as angiogenic structure formation. Treatment of PRF resulted in: - increased cell viability* - higher expression of osteogenic differentiation factors* - higher release of osteogenic growth factors* - increased formation of microvessel-like structures* (*compared to untreated control) What is the impact? PRF represents a beneficial autologous tool for regenerative purposes combining proosteogenic and proangiogenic properties. Therefore, PRF might be used for applications in versatile fields of medicine in the context of improving bone tissue regeneration.
cell biology,hematology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the effect of platelet - rich fibrin (PRF) as a bioactive matrix on the proosteogenic and proangiogenic properties of human healthy primary cells (especially osteoblasts and human dermal microvascular endothelial cells) under in vitro conditions. Specifically, the study focused on the influence of PRF on osteoblast differentiation and angiogenesis, especially the influence of PRF with different relative centrifugal forces (RCF) prepared under the low - speed centrifugation concept (LSCC) on these processes. The paper explores this problem through the following aspects: 1. **Proliferation and Differentiation of Osteoblasts**: The influence of PRF treatment on the proliferation and differentiation of osteoblasts was studied, including gene and protein expression analysis and immunofluorescence detection. 2. **Release of Osteogenic Growth Factors**: The concentration changes of osteogenic growth factors (such as transforming growth factor β1, TGF - β1 and platelet - derived growth factor - BB, PDGF - BB) in osteoblasts after PRF treatment were evaluated. 3. **Formation of Angiogenic Structures**: In the co - culture system of osteoblasts and endothelial cells, the influence of PRF treatment on the formation of angiogenic structures was studied, especially by detecting the expression of endothelial cell - specific marker CD31 through immunofluorescence staining. 4. **Effect Comparison of PRF with Different Centrifugal Forces**: The influence of PRF prepared with low relative centrifugal force (44 g) and high relative centrifugal force (710 g) on the above - mentioned indicators was compared. Through these studies, the paper aims to verify the potential application value of PRF as an autologous tool with proosteogenic and proangiogenic properties in bone tissue regeneration.